APA (7th ed.) Citation

Bruckert, E., Caprio, S., Wiegman, A., Charng, M., Zárate-Morales, C. A., Ajari, I., . . . Daniels, S. R. (2021). THE EFFICACY AND SAFETY OF ALIROCUMAB IN CHILDREN AND ADOLESCENTS WITH HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA (HOFH): PHASE 3, MULTINATIONAL OPEN-LABEL STUDY. Journal of the American College of Cardiology, 77(18), 441. https://doi.org/10.1016/S0735-1097(21)01800-3

Chicago Style (17th ed.) Citation

Bruckert, Eric, et al. "THE EFFICACY AND SAFETY OF ALIROCUMAB IN CHILDREN AND ADOLESCENTS WITH HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA (HOFH): PHASE 3, MULTINATIONAL OPEN-LABEL STUDY." Journal of the American College of Cardiology 77, no. 18 (2021): 441. https://doi.org/10.1016/S0735-1097(21)01800-3.

MLA (9th ed.) Citation

Bruckert, Eric, et al. "THE EFFICACY AND SAFETY OF ALIROCUMAB IN CHILDREN AND ADOLESCENTS WITH HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA (HOFH): PHASE 3, MULTINATIONAL OPEN-LABEL STUDY." Journal of the American College of Cardiology, vol. 77, no. 18, 2021, p. 441, https://doi.org/10.1016/S0735-1097(21)01800-3.